MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 377 filers reported holding MEDIVATION INC in Q1 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $51,382,000 | +438.3% | 852,100 | +310.5% | 0.10% | +444.4% |
Q1 2016 | $9,545,000 | -67.7% | 207,600 | -70.1% | 0.02% | -74.3% |
Q3 2015 | $29,525,000 | -67.5% | 694,700 | -12.6% | 0.07% | -66.2% |
Q2 2015 | $90,800,000 | +62.0% | 795,100 | +83.1% | 0.21% | +73.9% |
Q1 2015 | $56,046,000 | +118.8% | 434,231 | +68.9% | 0.12% | +91.9% |
Q4 2014 | $25,610,000 | +138.2% | 257,100 | +136.5% | 0.06% | +113.8% |
Q3 2014 | $10,750,000 | +79.2% | 108,728 | +15.7% | 0.03% | +107.1% |
Q4 2013 | $5,999,000 | – | 94,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |